Where healthcare owners, investors and advisors connect.

Most investors are underwriting durability before they underwrite growth. In healthcare services that usually means a revenue base that does not depend on a single payer, a single referral source or a single clinician; a reimbursement position that is understood rather than assumed; and a clinical and administrative model that can be repeated in a second location without the founder present.

Quality of earnings matters more than headline margin. Owner compensation, related-party property, non-recurring items and under-invested capex all get normalized, and businesses that have already done that work internally negotiate from a stronger position.

A frequent gap is management depth. A business where the owner is the primary clinical, commercial and operational decision-maker is harder to underwrite than one with a second layer of leadership — regardless of how good the numbers look.

Earlier than most owners expect, and for reasons that have little to do with selling. The decisions that shape a transaction outcome — how contracts are documented, whether property sits inside or outside the operating entity, how the leadership team is structured, how reliably financial information can be produced — take one to three years to change and cannot be retrofitted during a process.

Preparation is also optionality. An owner who has done the work can choose to sell, to bring in a minority partner, to recapitalize, or to do nothing at all. An owner who has not done the work is effectively choosing between selling on someone else's terms and waiting.

Starting early does not commit you to anything. It simply means that when the right conversation arrives, you are in a position to have it.

The right advisor is a question of fit, not league tables. Three things tend to matter most: relevant sector experience at your size of business, genuine access to the specific buyer universe that would want to own your company, and clarity about who will actually run the process day to day.

Ask directly which comparable mandates the team has executed, who the senior person on the deal will be, and how the fee structure aligns their incentives with yours. Ask what they would tell you not to do. An advisor who only agrees with you is not adding much.

Owners frequently meet only the advisors who happen to approach them first. A short, structured comparison of two or three genuinely relevant firms usually produces a better process — and costs nothing but a few conversations.

Fragmentation is a precondition for buy-and-build, not a strategy. The markets where consolidation works tend to share a few characteristics: an ageing owner base, real operating leverage from shared infrastructure, and a regulatory or reimbursement framework stable enough to underwrite a multi-year plan.

The constraint is almost never the availability of targets. It is the availability of targets whose owners are willing to have a conversation, at a moment when they are willing to have it. That is an origination problem and a relationship problem before it is a valuation problem.

Platforms that build a proprietary channel to owners early — rather than competing for the same intermediated processes — generally acquire at more sensible entry multiples and integrate more successfully, because the relationship preceded the negotiation.

The distinction is less about price than about what happens afterwards. A strategic buyer is usually acquiring capability, capacity or market position, and will often integrate the business into an existing structure — which can mean a cleaner full exit for the owner but less continuity for the team and the brand.

A financial buyer is generally acquiring a platform, and typically wants the owner to remain involved and to retain equity in the next phase. That can be attractive to an entrepreneur who is not ready to stop, and unattractive to one who is.

Neither is inherently better. The right answer depends on what the owner wants their role, the company and their proceeds to look like in three to five years — which is why that question is worth settling before a process begins, not during one.

Healthcare businesses concentrate succession risk in an unusual way, because the founder is often simultaneously the clinical authority, the commercial relationship and the cultural centre of the organisation. Replacing that is rarely a single hire.

Succession also has more than one form. A full sale is only one route; a partial exit, a phased handover to internal leadership, or a minority investment that funds a management build-out can each achieve the founder's objective with less disruption.

The practical test is straightforward: what happens to the business if the founder is unavailable for six months? Where the honest answer is uncomfortable, that is usually the work to do first — and it improves the business whether or not a transaction ever follows.